Fingerprint
Dive into the research topics of 'A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
Stacy Moulder, Gregory Gladish, Joe Ensor, Ana Maria Gonzalez-Angulo, Massimo Cristofanilli, James L. Murray, Daniel Booser, Sharon H. Giordano, Abeena Brewster, Julia Moore, Edgardo Rivera, Gabriel N. Hortobagyi, Hai T. Tran
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations